-
-
-
-
-
-
-
Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
-
-
-
-
-
-
-
Organovo Holdings, Inc. Announces Adjournment of Special Meeting of Stockholders
-
-
-
-
-
-
-
The Case Against Tarveda: An Open Letter to Organovo Shareholders
-
-
-
-
-
-
-
Viscient Biosciences Proposes Merger to Unlock 3D Bioprinting Potential in Drug Discovery With Organovo
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/16: (ERI) (ALKS) (DVAX) Higher; (CLDX) (ALGT) (NLNK) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 07/11: (BLFS) (SGNT) (IMPV) Higher; (CJES) (TWTR) (CHTR) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/22: (PKT) (ONVO) (ANGI) Higher; (NRP) (CMG) (URI) Lower (more...)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

